NCT05744466View on ClinicalTrials.gov

A Real-world Observational Study to Compare Effectiveness of Deucravacitinib Vs Apremilast in Adults With Plaque Psoriasis

RecruitingOBSERVATIONAL
Enrollment

1,500

Participants

Timeline

Start Date

September 30, 2022

Primary Completion Date

December 10, 2027

Study Completion Date

December 10, 2027

Conditions
Psoriasis
Interventions
DRUG

Deucravacitinib

As prescribed by treating clinician

DRUG

Apremilast

As prescribed by treating clinician

Trial Locations (1)

02451

RECRUITING

Local Institution, Waltham

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT05744466 - A Real-world Observational Study to Compare Effectiveness of Deucravacitinib Vs Apremilast in Adults With Plaque Psoriasis | Biotech Hunter | Biotech Hunter